Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity

J Am Coll Cardiol. 2024 Nov 18:S0735-1097(24)10422-6. doi: 10.1016/j.jacc.2024.11.008. Online ahead of print.
No abstract available

Keywords: cardiovascular disease; coronary artery bypass graft; major cardiovascular adverse event; obesity; overweight.